Login / Signup

Interaction of Alt a 1 with SLC22A17 in the airway mucosa.

Maria Garrido-ArandiaJaime Tome-AmatDiego Pazos-CastroVanesa EstebanMaria M EscribeseGuadalupe Hernández-RamírezAlma Yuste-MontalvoDomingo BarberLuis F PaciosisArazeli Diaz Perales
Published in: Allergy (2019)
Our findings identified the Alt a 1 ligand as a central player in the interaction of the allergen with airway mucosa, shedding light into its potential role in the immunological response, while unveiling its potential as a new target for therapy intervention.
Keyphrases
  • randomized controlled trial
  • allergic rhinitis
  • cell therapy